John TaylorGlobal Head of Business Development at RibocureSpeaker
Agenda Sessions
RNA Partnerships of Big Pharma, Biotech, Industry Providers
, 08:55View SessionUsing siRNA to target Cardiovascular diseases, working from Discovery to Clinical evaluation
, 11:35View Session